论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Sorcin:癌症治疗的新靶点
Authors Zhou X, Wu X, Chen B
Received 14 March 2019
Accepted for publication 5 July 2019
Published 5 August 2019 Volume 2019:11 Pages 7327—7336
DOI https://doi.org/10.2147/CMAR.S208677
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Nicola Ludin
Peer reviewer comments 4
Editor who approved publication: Dr Sanjeev Srivastava
Abstract: Soluble resistance-related calcium-binding protein (sorcin) is a member of the penta-EF-hand protein family. Sorcin is widely distributed in normal human tissues, such as the brain, heart, lymphocytes, kidneys, breast and skin. Findings suggest that sorcin is associated with the regulation of calcium homeostasis, cell cycle and vesicle trafficking. It has been reported that many types of non-neoplastic diseases such as diabetes, viral infection, infertility, and nervous system diseases were affected by the expression of sorcin. One of the main issues is the role of sorcin in neoplastic diseases. Research proved that sorcin can be found to overexpress in cells of several cancers, particularly in the case of multidrug-resistant cancers. Additionally, the researchers proposed that the expression of sorcin was significantly associated with the foundation of multidrug resistance (MDR). All the findings mentioned above emphasized the importance of studying sorcin. This review mainly includes the following aspects: functions of sorcin, role in non-neoplastic and neoplastic diseases, and research related to drugs. To sum up, sorcin is a potential novel target to be studied to deal with MDR.
Keywords: soluble resistance-related calcium binding protein, sorcin, multidrug resistance, MDR, cancer, chemotherapy